BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16459175)

  • 1. Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules.
    Yano S; Nishioka Y; Goto H; Sone S
    Cancer Sci; 2003 Jun; 94(6):479-85. PubMed ID: 12824870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel vascular targets in lung cancer.
    Zhuang X; Herbert JM; Lodhia P; Bradford J; Turner AM; Newby PM; Thickett D; Naidu U; Blakey D; Barry S; Cross DA; Bicknell R
    Br J Cancer; 2015 Feb; 112(3):485-94. PubMed ID: 25535734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The realisation of targeted antitumour therapy.
    Bicknell R
    Br J Cancer; 2005 Jun; 92 Suppl 1(Suppl 1):S2-5. PubMed ID: 15928654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target therapies in lung cancer.
    Bearz A; Berretta M; Lleshi A; Tirelli U
    J Biomed Biotechnol; 2011; 2011():921231. PubMed ID: 21541198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II Study of Cabozantinib in Patients With Bone Metastasis.
    Choy E; Cote GM; Michaelson MD; Wirth L; Gainor JF; Muzikansky A; Sequist LV; Sullivan RJ; Fidias PM; Shaw A; Heist RS
    Oncologist; 2022 Jul; 27(7):600-606. PubMed ID: 35524758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Langer CJ; Natale RB
    Semin Oncol; 2005 Dec; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multitargeted inhibitors in lung cancer: new clinical data.
    Bar J; Herbst RS; Onn A
    Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiogenesis and lung cancer].
    PĂ©rol M; Arpin D
    Bull Cancer; 2007 Jul; 94 Spec No():S220-31. PubMed ID: 17846008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The actual place of anti-angiogenesis in non-small cell lung cancer].
    Mennecier B
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S198-205. PubMed ID: 18235414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting angiogenesis in lung cancer.
    Sandler AB
    Semin Oncol; 2005 Dec; 32(6 Suppl 10):S16-22. PubMed ID: 16459175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic therapy in nonsmall cell lung cancer.
    Gutierrez M; Giaccone G
    Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.